Ovid Therapeutics has initiated the Phase 2 ROCKET clinical trial to assess the safety, tolerability, and efficacy of OV101…
Articles by Alice Melão
Babies with fragile X syndrome have less-developed brain white matter compared to those without the syndrome, according to researchers. …
Mice that lack the gene responsible for fragile X syndrome have similar changes in brain activity in the auditory cortex as…
Patients with fragile X syndrome have faster protein synthesis and increased protein levels than healthy people, according to a recent…
GW Pharmaceuticals is going to increase its focus on the development of its investigational, cannabinoid-based therapy GWP42006 to treat…
Interventions focused on improving mindfulness and acceptance may promote the health and well-being of mothers who have children with…